One Pager as on August 31, 2024
Business Cycle fund aims to identify and invest in select sectors based on the market and economic dynamics. | |
Skilled fund managers can strategically rotate the portfolio`s sectoral allocation to capture outperformance during specific phases of the business cycle. | |
The Funds are designed to be flexible and adaptive to changing economic & market conditions. | |
Investing in a business cycle fund allows investors to participate in the growth potential of different sectors and industries as the economy progresses through different phases of the cycle. |
Blend of top-down Business Cycle/Sector identification and bottom-up stock selection approach. | |
Portfolio Allocation: Quality companies preferred during the favourable business cycle. | |
Concentrated sectoral position based on the stages of Business Cycle. | |
Investments across market capitalization. |
Security | % to Net Assets |
HDFC Bank Limited | 6.64% |
Infosys Limited | 4.09% |
Reliance Industries Limited | 3.53% |
Indus Towers Limited | 3.23% |
Hindustan Unilever Limited | 2.81% |
State Bank of India | 2.63% |
ITC Limited | 2.63% |
IndusInd Bank Limited | 2.41% |
Oil & Natural Gas Corporation Limited | 2.37% |
Divi's Laboratories Limited | 2.33% |
Total | 32.67% |
Data as on August 31, 2024
Sector | MMBCF* | Nifty 500 TRI |
Financial Services | 18.36% | 27.60% |
Oil Gas & Consumable Fuels | 14.62% | 8.75% |
Information Technology | 10.18% | 9.90% |
Healthcare | 9.20% | 5.96% |
Fast Moving Consumer Goods | 9.01% | 7.24% |
*MMBCF= Mahindra Manulife Business Cycle Fund
Data as on August 31, 2024
Fresh Additions | Complete Exits |
Security | Security |
Jio Financial Services Limited | Inox India Limited |
Mphasis Limited | LTIMindtree Limited |
Note: The companies/stock(s) referred above are only for the purpose of disclosure of significant portfolio changes during the month and should not be construed as recommendation to buy/sell/ hold. The fund manager may or may not choose to hold these companies/stocks, from time to time. Investors are requested to consult their financial, tax and other advisors before taking any investment decision(s). Data as on August 31, 2024
^Benchmark ^^Additional Benchmark. Inception/Allotment date: 11-Sep-23. .
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. Since inception returns of the scheme
is calculated on face value of Rs. 10 invested at inception. The performance details provided above are of Growth Option under Regular Plan. Different Plans i.e Regular Plan and Direct Plan under the scheme has different expense structure. *Based
on standard investment of Rs. 10,000 made at the beginning of the relevant period. Mr. Pranav Patel is managing this fund since January 05, 2024. Simple annualized returns have been provided as per the extant guidelines
since the scheme has completed 6 months but not 1 year.
^Benchmark CAGR – Compounded Annual Growth Rate. $Dedicated Fund Manager for Overseas Investments.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. The performance details provided above are of Growth Option under
Regular Plan. Different Plans i.e Regular Plan and Direct Plan under the scheme has different expense structure. Mr. Krishna Sanghavi manages 2 schemes, Mr. Renjith Sivaram manages 3 schemes and
Mr. Pranav Patel manages 5 schemes of Mahindra Manulife Mutual Fund. The performance data for the schemes which have not completed one year has not been provided.
Performance as on August 30, 2024
Note: As August 31, 2024 was a non - business day, the schemes returns disclosed are as on August 30,2024, except for Mahindra Manulife Liquid Fund and Mahindra Manulife Overnight Fund which
is as of August 31, 2024.
This product is suitable for investors who are seeking*:
• Long term capital appreciation;
• Investment predominantly in equity
and equity related instruments of
business cycle based theme.
*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.